G0S2 and glioblastoma: G0S2 was identified as a prospective biomarker in glioblastoma stem-like cells [60], and the methylation-induced downregulation of G0S2 was linked to the inhibited invasion of IDH1-mutant glioblastoma cells and an improved prognosis [61].